Latest News

Annual Report & Accounts

Publication of a company's annual financial report

ImmuPharma appoints interim chairman

ImmuPharma has confirmed that senior non-executive director Dr Franco Di Muzio will take on the role of chairman on...

Interim Board Change

Notification of any change to a company’s board e.g. appointments/resignations/changes to important functions or executive responsibilities of a director

ImmuPharma losses narrow

ImmuPharma posts an overall loss of 2.9m for the year ended 31 December - down from 3.7m last time. The decrease in ov...

All News

06-05-15Annual Report & AccountsRNS
06-05-15ImmuPharma appoints interim chairman StockMarketWire
06-05-15Interim Board ChangeRNS
30-04-15ImmuPharma losses narrow StockMarketWire
30-04-15Directorate ChangeRNS
30-04-15Preliminary ResultsRNS
11-02-15Immupharma completes clinical trial StockMarketWire
11-02-15CANCER UPDATE: IPP-204106RNS
27-01-15ImmuPharma gets assurance over EIS StockMarketWire
27-01-15Enterprise Investment Scheme StatusRNS
22-01-15FTSE surges as ECB unveils QE, financials riseStockMarketWire
22-01-15FTSE cautiously up as ECB's QE call nearsStockMarketWire
22-01-15Collaboration Agreement with Simbec-OrionRNS
30-10-14Holding(s) in CompanyRNS
28-10-14Holding(s) in CompanyRNS
21-10-14FTSE 100 makes strong recoveryStockMarketWire
21-10-14FTSE 100 bounces backStockMarketWire
21-10-14ImmuPharma raises £3.4m StockMarketWire
21-10-14Additional Listing - Conditional PlacingRNS
20-10-14ImmuPharma unit awarded €400,000 grant StockMarketWire
20-10-14ImmuPharma awarded EUR400,000 GrantRNS
30-09-14Losses remain at ImmuPharmaStockMarketWire
30-09-14Half Yearly ReportRNS
30-09-14LupuzorT Gears Up To Start Pivotal Phase III trialRNS
27-06-14Immupharma shareholders approve AGM resolutionsStockMarketWire
27-06-14Result of AGMRNS
27-06-14ImmuPharma extends research capabilitiesStockMarketWire
27-06-14Access to pioneering research in Bordeaux FranceRNS
16-06-14ImmuPharma granted new Nucant patents StockMarketWire
23-05-14Annual Financial ReportRNS
21-05-14ImmuPharma pre-tax losses riseStockMarketWire
21-05-14Preliminary ResultsRNS
06-05-14ImmuPharma gives summary from lupus conference StockMarketWire
06-05-14Dr. Sylviane Muller - Presentation AbstractRNS
23-04-14Lupuzor founder presents at Osaka UniversityStockMarketWire
23-04-14Dr. S Muller, founder of Lupuzor presentation.RNS
11-04-14ImmuPharma Sponsors the 2014 European Lupus ConferRNS
14-10-13Additional ListingRNS
27-09-13ImmuPharma trims operating lossStockMarketWire

RSS feeds

  • Editorial news feed for LSE:IMM Editorial
  • Regulatory news feed for LSE:IMM Regulatory